Cancer Research

Key to detecting ovarian cancer early may be in the fallopian tubes

A lack of early detection or prevention strategies for ovarian cancer is a major cause of poor outcomes for patients, and most do not have a family history or inherited genetic risk, so there is a pressing need for the development of earlier detection methods.

Caren Begun

Links between diet and cancer

Kathryn E. Wellen, an associate professor of Cancer Biology and principal investigator of the Wellen Lab, seeks answers to find the connections between metabolism and cancer biology.

From Penn Medicine News

Media Contact


In the News

Philadelphia Inquirer

This new ovarian cancer treatment could improve survival rates | 5 Questions

Janos L. Tanyi of the Perelman School of Medicine spoke about a large-scale trial of Cytalux, which makes cancer cells glow during surgery, being conducted at the Abramson Cancer Center. “Those patients who have all the visible cancerous lesions removed have the best survival rates,” he said.


ABC Australia

How should cancer immunotherapy be used?

Ravi Parikh of the Perelman School of Medicine was interviewed about his research on the use of new and expensive immunotherapy medications to treat cancer patients considered to be ineligible for clinical trials. These older, sicker patients turned out be “about twice as likely to receive these novel immunotherapies compared to healthier patients who would have been included, and this is despite the fact that these drugs have never been studied in this particular group of individuals,” said Parikh.


BRCA1 vs. BRCA2: What to know about these gene mutations and breast cancer

Payal Shah of the Perelman School of Medicine discussed the gene mutations that can lead to breast, ovarian, and other cancers.


Philadelphia Inquirer

More Black patients are participating in clinical trials for cancer treatment at Penn thanks to this effort

Carmen Guerra and Armenta Washington of the Abramson Cancer Center spoke about their efforts to enroll more Black patients with cancer in clinical trials. “When we conduct research, we want to say that what we learn applies to all people,” said Guerra. “But that might not be the case if we are just studying one population.”


CBS News

Cancer Moonshot project launched by President Biden 5 years ago leading to many breakthroughs

Robert Vonderheide of Penn’s Abramson Cancer Center in the Perelman School of Medicine spoke about the Cancer Moonshot project, which has led to major federal funding for cancer research and subsequently, new treatments for patients. “It’s new initiatives, new therapies, and new ways importantly to prevent cancer in the first place,” he said.


The Washington Post

For those at risk for cancer, weighing the risk of COVID-19 with delays in screening and treatment

Lawrence Shulman of the Perelman School of Medicine says declining numbers of new cancer diagnoses over the past four months don’t mean fewer people actually have cancer. “There are a lot of patients out there who have cancer but are not undergoing diagnosis and entry into the cancer care system,” he said.